UN Human Rights Council Resolutions on Access to Medicines and the Use of TRIPS Flexibilities: A Review
By Nirmalya Syam
This paper reviews almost twenty years of the United Nations Human Rights Council’s (UNHRC) work on access to medicines. The UNHRC has repeatedly framed access to medicines as part of the right to health and has urged States to rely on flexibilities in the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) to make essential treatments more affordable. Although the UNHRC has strengthened the human rights foundation for using such flexibilities, its resolutions have produced little change on the ground. The commitments embodied in the UNHRC resolutions stay broad and non-binding, leaving the deep structural barriers in place, including restrictive intellectual property (IP) clauses in trade deals, pressure from powerful States, limited technical and manufacturing capacity, and weak policy coordination within governments. Moreover, several recent resolutions reaffirm the value of IP protection, which creates tension that dilutes the Council’s support for the wider use of TRIPS flexibilities. The paper finds that the main gap between global human rights commitments and national action on advancing access to medicines reflects political choices and structural barriers, and concludes by calling for stronger mandates for States to review access barriers during the Universal Periodic Review, increased technical assistance from the Office of the High Commissioner for Human Rights, more civil society participation, national right-to-health action plans, and systematic monitoring of TRIPS implementation.
Health Equity in Global Governance: growing recognition in need of concrete actions
By Carlos M. Correa
Health equity is a foundational principle of global health governance that should ensure all individuals have fair and just opportunities to achieve optimal health, regardless of social, economic, or geographical disparities. The right to health is recognized as a fundamental human right in Article 12 of the International Covenant on Economic, Social and Cultural Rights (ICESCR). This document explores the concept of health equity drawing on United Nations General Assembly (UNGA) resolutions and key instruments from the World Health Organization (WHO). It discusses the challenges and opportunities for developing countries in pursuing equitable health outcomes, including advancing sexual and reproductive health and rights.
Experiences and Challenges Faced by Sri Lanka in Implementing the Highest Attainable Standard of Health, Including Health Equity and Sexual and Reproductive Health and Rights
By Janani Sivapakthan
Sri Lanka’s long-standing commitment to free and equitable healthcare with a focus on primary healthcare has yielded impressive achievements in health equity, maternal and child health, disease elimination, and sexual and reproductive health and rights. However, Sri Lanka faces challenges in upholding health equity in the context of escalating domestic and global pressures. Safeguarding the highest attainable standard of health for all Sri Lankans requires addressing underinvestment, workforce migration, uneven service distribution, and the emerging burden of non-communicable diseases in a context of economic constraint.
Promoting Health Equity and Reproductive Rights in Angola
By Sandra Benge Neto
This article examines Angola´s progress in rebuilding its health system in the post conflict era, focusing on health equity and the promotion of Sexual and Reproductive Health and Rights (SRHR) in alignment with the Protocol to the African Charter on Human and Peoples’ Rights on the Rights of Women in Africa (Maputo Protocol) and international human rights commitments.
Despite significant advances – such as the expansion of primary healthcare, municipalization of services, and youth–friendly centres – Angola continues to face challenges including geographic disparities, sociocultural barriers to contraception, insufficient funding, and limited data systems. Drawing from national initiatives and community based experiences, this article highlights best practices and strategic recommendations to accelerate Angola´s implementation of the Maputo Protocol and achieve universal, gender–responsive health coverage.
Brazil’s challenges in implementing the highest attainable standard in Sexual and Reproductive Health and Rights
By Camila C. Gasparro
This paper examines Brazil’s efforts to improve women’s Sexual and Reproductive Health and Rights. Brazil is making progress through the Ministry of Health and collaborative engagement with social movements. However, persistent structural barriers continue to disproportionately undermine women’s sexual and reproductive rights, particularly among Black, Indigenous, and vulnerable populations.
South Centre Supports Civil Society and Research Institutions in the Global South to Raise Awareness of Antimicrobial Resistance during World Antimicrobial Resistance Awareness Week 2025
by Viviana Munoz Tellez, Ningxiner Li
The South Centre supported multiple civil society institutions across the Global South to implement targeted awareness raising campaigns on antimicrobial resistance (AMR) and commemorate the World Antimicrobial Resistance Awareness Week (WAAW) 2025, with funding provided by the United Kingdom Fleming Fund. The selection of campaigns was prioritized based on the quality of the proposals and their implementation in South Centre Member Countries.
The US Bilateral Specimen Sharing Agreement in the Proposed PEPFAR MOUs Would Leave African Countries More Vulnerable in the Next Pandemic
By Nirmalya Syam, Viviana Munoz Tellez
This Policy Brief examines the implications of the United States’ (US) PEPFAR Memorandum of Understanding (PEPFAR MOU) proposed to African countries on the negotiations for a multilateral system for access to pathogens and benefit sharing (PABS) as part of the World Health Organization’s (WHO) Pandemic Agreement. It recommends that African countries do not accept the MOU provisions on specimen sharing and data access that undermine national sovereignty and calls for a coordinated regional response.
Independent Panel on Evidence for Action against Antimicrobial Resistance (IPEA): Reflections on the Foundational Documents
By Dr. Viviana Munoz Tellez
The United Nations General Assembly (UNGA) invited the Quadripartite Organizations to establish an Independent Panel on Evidence for Action against Antimicrobial Resistance (IPEA) in 2025. The launch of the IPEA is planned for 10 December 2025 during the United Nations Environment Assembly (UNEA). The Quadripartite organizations (the Food and Agriculture Organization (FAO), the United Nations Environment Programme (UNEP), the World Health Organization (WHO) and the World Organisation for Animal Health (WOAH)) released in November 2025 updated draft documents for the IPEA for additional consultation with Member States and stakeholders. The IPEA will constitute a welcome addition to global Antimicrobial Resistance (AMR) governance, and should be established, starting small and building gradually. Several concerns on the proposed model remain concerning the governance structure, equity in participation, and the independence of the panel. This policy brief provides analysis and recommendations on key issues concerning the draft foundational documents for the IPEA requiring attention.
Africa Region + Egypt, Libya, Somalia, Sudan and Group for Equity Lead 80-Country Push for Fair Pathogen Access and Benefit Sharing System
At the start of IGWG4, in a remarkable show of unity by developing countries, the Africa Group (AG) and Group for Equity jointly made a statement representing 80 developing countries. This extraordinary demonstration of unity represents a powerful and inspiring moment in global health governance, as this unified bloc is championing equal footing for rapid access to pandemic materials and digital sequence information (DSI) on the one hand, and on the other hand, the ability to rapidly access vaccines, therapeutics, and diagnostics (VTDs), along with accelerated research, knowledge and technology sharing, needed to prevent and respond to pandemics.
Analysis of the European Union Proposal on the Pandemic Agreement Annex dated 17 October 2025
South Centre
This note is prepared to provide South Centre Member States and other developing country delegations with analytical comments on the proposal of the European Union (EU) on the Annex to the Pandemic Agreement, implementing the Pathogen Access and Benefit Sharing (PABS) System as established in Article 12. The note begins with general commentary on the proposal, followed by detailed analysis of the EU proposal text, which is marked in red below the transcribed text.
Participation of South Centre Member Countries in the WHO GLASS: Progress and Gaps in AMR Surveillance and Stewardship Efforts
By Dr. Rasha Abdelsalam Elshenawy
This study highlights antimicrobial resistance (AMR) surveillance challenges in LMICs, focusing on the 55 South Centre Member States’ enrolment in the WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS). Despite progress since its 2016 launch, significant gaps persist: only 60 percent of South Centre Member States report AMR surveillance to GLASS, and just 38 percent report antimicrobial use (AMU) data to GLASS. The COVID-19 pandemic substantially disrupted surveillance activities, with rates declining from 2020-2021 compared to pre-COVID-19 pandemic levels. Digital infrastructure, such as mobile reporting tools, cloud-based systems, and interactive dashboards, offers significant opportunities to strengthen AMR surveillance in resource-limited settings. The study recommends a holistic and phased approach for South Centre Member States, including developing integrated national AMR action plans with realistic implementation timelines, investing in laboratory and workforce development, establishing interoperable digital infrastructure, and strengthening regional collaboration mechanisms. By systematically addressing core surveillance challenges while strategically incorporating digital innovations where appropriate, countries can develop resilient monitoring systems that support effective stewardship, protect national populations, and contribute to global health security by preserving antimicrobial effectiveness for future generations.
Implementing Evidence-based Antimicrobial Prescribing to Combat AMR and Strengthen Global Stewardship – The GUIDE Framework in Action
Monday, 17 November 2025, 12:00-13:00 CET/11:00-12:00 UK/06:00-7:00 EDT/15:30-16:30 IST
Join us for the launch of a new evidence-based tool to enhance antimicrobial prescribing and stewardship. Share your feedback to help us strengthen its value and usability for global practice.
